InvestorsHub Logo
Followers 33
Posts 1609
Boards Moderated 0
Alias Born 10/06/2015

Re: Learning53 post# 232024

Monday, 04/22/2024 3:45:03 AM

Monday, April 22, 2024 3:45:03 AM

Post# of 232192
In some cases Leronlimab (or Leronmybud LL) will "carry the ball across the goal," (Especially where CCR5 is involved) but more frequently, it would be a valuable adjuvant. And the, so far, minimal negative side-effects... give it some interesting advantages.

And

Makes >> LL >>> A THREAT <<< to competing drugs carrying "heavy side-effect disadvantages."

So spin us a tale on ...HOW >>>Roger Stone get some LL for his wife with (reputedly) good results?

And it seems some other "biggies" got some.

But now >>> LL could gradually, become the Newest Drug. A drug that seems to support health by helping to counter chronic inflammation. But LL's not a magic bullet.

A lot of factors apply - like what are you're eating, breathing, sharing, and on and on, etc.

But Leronlimab, Leronmybud, is something I want available.

My Opinion totally!!

***

And, sorry big-bully Pharma. We could have been working together, but events have a path of their own,
Imagine

Leronlimab
Could be

Popping up

Leronmybud

And they have their own
"on-line Docs"

to do the scripts ;)

Always entirely my opinion - do your own research
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News